68964-95-4 Usage
Uses
Used in Pharmaceutical Industry:
Prodelphinidin B4 is used as a pharmaceutical agent for its tumor-inhibiting properties. It is derived from green tea, which is known for its health benefits and cancer-fighting potential.
Used in Anticancer Applications:
Prodelphinidin B4 is used as an anticancer agent, leveraging its ability to inhibit tumor growth and potentially contribute to cancer treatment and prevention strategies.
Used in Nutraceutical Industry:
Prodelphinidin B4 can be used as a nutraceutical ingredient, given its presence in green tea and its potential health benefits, including its role in cancer prevention and treatment.
Used in Cosmetic Industry:
Prodelphinidin B4 may be used in cosmetic products for its potential skin health benefits, such as providing antioxidant protection and potentially reducing the risk of skin cancer.
Used in Food and Beverage Industry:
Prodelphinidin B4 can be incorporated into food and beverage products as a functional ingredient, capitalizing on the health-promoting properties of green tea and its constituents.
Check Digit Verification of cas no
The CAS Registry Mumber 68964-95-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,9,6 and 4 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 68964-95:
(7*6)+(6*8)+(5*9)+(4*6)+(3*4)+(2*9)+(1*5)=194
194 % 10 = 4
So 68964-95-4 is a valid CAS Registry Number.
68964-95-4Relevant academic research and scientific papers
Syntheses of prodelphinidin B1, B2, and B4 and their antitumor activities against human PC-3 prostate cancer cell lines
Fujii, Wataru,Toda, Kazuya,Matsumoto, Kiriko,Kawaguchi, Koichiro,Kawahara, Sei-Ichi,Hattori, Yasunao,Fujii, Hiroshi,Makabe, Hidefumi
supporting information, p. 7188 - 7192 (2013/12/04)
Total synthesis of prodelphinidin B1, B2, and B4 has been accomplished. The key step is Lewis acid-mediated equimolar condensations between an epigallocatechin and/or a gallocatechin nucleophile and an epigallocatechin and/or a gallocatechin electrophile. The antitumor effects of synthetic prodelphinidin B1-B4 against human PC-3 prostate cancer cell lines have been investigated. These compounds showed significant antitumor effects. Their activity seemed to be little bit stronger than EGCG and prodelphinidin B3, known antitumor agent.
